Jeppe Øvlesen

Jeppe Øvli Øvlesen was the founder of ChemoMetec A, founded in 1998, where the title held was Chief Executive & Financial Officer from 1998 to 2003.
Mr. Øvlesen was the founder of Getinge Cetrea A, founded in 2007, with the title Director from 2007 to 2012.
Mr. Øvlesen was the founder of Mindway AI ApS, founded in 2018, serving as Chairman & Chief Executive Officer from 2018 to 2019.
Mr. Øvlesen is the founder of SynAct Pharma AB, founded in 2024, currently holding the titles Chief Executive Officer & Director since 2024.
Mr. Øvlesen is also the founder of QIAGEN Aarhus A,PNN Medical A,TXP Pharma GmbH..
Mr. Øvlesen is currently Chairman at Vikarbasen A since 2009, Chairman at Neurescue ApS since 2020, Chairman at Go-Pen ApS, Chairman at Cereno Scientific AB starting 2025, Chairman at Cercare Medical A, Director at Enovacor ApS since 2013, Director at Sundialog A, Director at ResoTher Pharma AS since 2018, Director at Perfusion Tech ApS since 2017, and Member-Executive Board at Corporate Culture ApS since 2014.
Former positions include Chief Executive Officer at PNN Medical SA, Chief Executive Officer at SynAct Pharma AB from 2014 to 2023, Chief Executive Officer at Cercare Medical A from 2017 to 2020, Director at NordEnergie Renewables A from 2005 to 2013, Director at Vintage Cloud A from 2015 to 2019, Independent Director at Monsenso A, Director at CPHI-Holding A from 2016 to 2018, Director at ACT.Global A in 2018, Chief Financial Officer & VP-Business Development at Action Pharma A from 2009 to 2011, Member-Executive Board at Vingmed Danmark A from 2015 to 2018, and Member-Executive Board at Quantass ApS from 2013 to 2020.
Education includes an MBA degree from the University of Hartford.